In recent months, several legislative acts have been adopted that significantly affect the regulation of medicinal products, specifically: A ban on advertising information on the labeling and information about persons other than the Manufacturer and MAH (marketing authorization holder), which comes into effect on January 18, 2025; Parallel import of medicines purchased by an authority […]
On 27th June, 2018, an external audit of pharmacovigilance processes in Cratia Ltd has been conducted by Ferrer International.
“Cratia Ltd” provides pharmacovigilance processes in Ukraine for variety of national and foreign pharmaceutical companies.
In June 2018, “Ferrer”, an international medical product manufacturer, conducted GVP audit of processes that are being carried out for this company by “Cratia Ltd” in Ukraine.
During the audit, it was confirmed that all pharmacovigilance processes for which “Cratia Ltd” is responsible are conducted in accordance with the requirements of European and Ukrainian legislation and in accordance with the signed Safety Data Exchange Agreement between our companies. Also, there were no critical findings during the audit, all other findings and recommendations were closed in prompt manner according to a CAPA-plan developed in collaboration.
Thus, the pharmacovigilance processes that provide “Cratia Ltd” in Ukraine for their partners are in compliance with the requirements of Ukrainian and European legislation, as well as the requirements of the Customer company.
Stay informed - subscribe to our newsletter.